Breaking News Instant updates and real-time market news.

PODD

Insulet

$34.91

-0.3 (-0.85%)

15:03
11/30/16
11/30
15:03
11/30/16
15:03

Insulet mentioned cautiously again by SkyTides

Skytides, which posted online another cautious research report on Insulet yesterday, is now tweeting regarding its negative stance on the company. Reference Link

PODD Insulet
$34.91

-0.3 (-0.85%)

09/29/16
COWN
09/29/16
NO CHANGE
COWN
Outperform
Cowen says views on Dexcom, Insulet not changed by competitor launches
Cowen analyst Doug Schenkel noted that Abbott (ABT) announced yesterday it had received FDA approval for the professional version of its FreeStyle Libre glucose monitoring product and filed the consumer version of Libre, while Medtronic (MDT) also announced FDA approval of its 670G Hybrid Closed Loop system. Schenkel said Abbott's consumer Libre filing comes a few months ahead of his expectations but that Medtronic's timing was in-line with expectations. The analyst said the competitor announcements, which had been expected, do not change his views on DexCom (DXCM), Insulet (PODD), or Tandem Diabetes (TNDM) and he keeps Outperform ratings on all three of those stocks.
09/29/16
BARD
09/29/16
NO CHANGE
BARD
Dexcom, Insulet could be weighed down by competitive concerns, says Baird
Baird analyst Jeff Johnson said that while the FDA approvals announced yesterday for Abbott's (ABT) FreeStyle Libre Pro and Medtronic's (MDT) 670G were largely anticipated, he believes that both approvals came sooner than most expected, as did news that Abbott also recently filed for FDA approval of its consumer Libre system. The approvals could "change the narrative" in diabetes and could weigh on others in the sector in the near-term, most notably Dexcom (DXCM) and Insulet (PODD), Johnson tells investors. He keeps Neutral ratings on both and maintains an Overweight rating on Tandem Diabetes (TNDM), citing valuation for the difference.
09/30/16
LEER
09/30/16
NO CHANGE
Target $55
LEER
Outperform
Insulet price target raised to $55 from $50 at Leerink
Leerink analyst Danielle Antalffy raised her price target for Insulet to $55 saying the company's drug delivery business is currently underappreciated and could represent at least $1.5B in sales. Further, the analyst estimates the OmniPod business will continue to grow at a rate of 15%-20% per year for the next few years. Antalffy keeps an Outperform rating on Insulet.
11/04/16
BTIG
11/04/16
UPGRADE
Target $42
BTIG
Buy
Insulet upgraded to Buy from Neutral at BTIG
BTIG analyst Sean Lavin upgraded Insulet to Buy with a $42 price target siting two quarters in a row of impressive core OmniPod growth combined with efficiency gains on margins. The analyst is confident management will hit long-term 65% gross margin goals and said weakness surrounding the medtech meltdown and competitive worries have created a buying opportunity.

TODAY'S FREE FLY STORIES

ICPT

Intercept

$73.70

-24.42 (-24.89%)

09:31
09/22/17
09/22
09:31
09/22/17
09:31
Downgrade
Intercept rating change  »

Citi downgrades Intercept…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MHK

Mohawk

09:31
09/22/17
09/22
09:31
09/22/17
09:31
Downgrade
Mohawk rating change  »

Mohawk downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UFCS

United Fire Group

$42.02

-0.12 (-0.28%)

09:30
09/22/17
09/22
09:30
09/22/17
09:30
Upgrade
United Fire Group rating change  »

United Fire Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
09/22/17
09/22
09:30
09/22/17
09:30
General news
PMI Composite Flash Manufacturing â€' Level to be reported at 09:45 »

September PMI Composite…

09:30
09/22/17
09/22
09:30
09/22/17
09:30
General news
PMI Composite Flash â€' Level to be reported at 09:45 »

September PMI Composite…

YOGA

YogaWorks

$4.00

-0.04 (-0.99%)

09:28
09/22/17
09/22
09:28
09/22/17
09:28
Recommendations
YogaWorks analyst commentary  »

YogaWorks shares remain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IP

International Paper

09:28
09/22/17
09/22
09:28
09/22/17
09:28
Hot Stocks
International Paper to invest about $300M to convert Riverdale paper machine »

International Paper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDTI

Integrated Device

$27.00

-0.16 (-0.59%)

09:26
09/22/17
09/22
09:26
09/22/17
09:26
Recommendations
Integrated Device analyst commentary  »

Integrated Device chip…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 05

    Oct

09:25
09/22/17
09/22
09:25
09/22/17
09:25
Conference/Events
DA Davidson engineering analyst holds an analyst/industry conference call »

Engineering &…

RBS

RBS

09:24
09/22/17
09/22
09:24
09/22/17
09:24
Upgrade
RBS rating change  »

RBS upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COR

CoreSite Realty

09:23
09/22/17
09/22
09:23
09/22/17
09:23
Initiation
CoreSite Realty initiated  »

CoreSite Realty initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

CONE

CyrusOne

$60.41

-0.35 (-0.58%)

09:22
09/22/17
09/22
09:22
09/22/17
09:22
Initiation
CyrusOne initiated  »

CyrusOne initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

, S

Sprint

09:21
09/22/17
09/22
09:21
09/22/17
09:21
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: T-Mobile US…

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

S

Sprint

EARS

Auris Medical

$0.71

0.0101 (1.44%)

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

VSAR

Versartis

$21.60

-0.25 (-1.14%)

FINL

Finish Line

$9.22

-0.21 (-2.23%)

FL

Foot Locker

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 27

    Sep

  • 02

    Oct

  • 16

    May

BWA

BorgWarner

, SEV

Sevcon

$22.00

-0.01 (-0.05%)

09:21
09/22/17
09/22
09:21
09/22/17
09:21
Conference/Events
Sevcon to host special shareholder meeting »

Special Shareholder…

BWA

BorgWarner

SEV

Sevcon

$22.00

-0.01 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

ICPT

Intercept

$73.70

-24.42 (-24.89%)

09:19
09/22/17
09/22
09:19
09/22/17
09:19
Downgrade
Intercept rating change  »

Intercept downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLR

Digital Realty

09:18
09/22/17
09/22
09:18
09/22/17
09:18
Initiation
Digital Realty initiated  »

Digital Realty initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

, VIX

Volatility Index S&P 500 Options

09:18
09/22/17
09/22
09:18
09/22/17
09:18
Options
Overnight activity included 125 trades in SPX and 21 trades in VIX »

125 trades were executed…

SPX

S&P 500

VIX

Volatility Index S&P 500 Options

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

09:17
09/22/17
09/22
09:17
09/22/17
09:17
Hot Stocks
Conagra Brands to acquire Angie's Artisan Treats, terms not disclosed »

Conagra Brands announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 28

    Sep

09:15
09/22/17
09/22
09:15
09/22/17
09:15
General news
Euro$ interest rate futures have continued to steady »

Euro$ interest rate…

09:15
09/22/17
09/22
09:15
09/22/17
09:15
General news
Breaking General news story  »

Kansas City Federal…

HDSN

Hudson Technologies

$8.47

-0.79 (-8.53%)

09:14
09/22/17
09/22
09:14
09/22/17
09:14
Recommendations
Hudson Technologies analyst commentary  »

Roth says Hudson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

ACN

Accenture

09:11
09/22/17
09/22
09:11
09/22/17
09:11
Recommendations
Accenture analyst commentary  »

Accenture risk/reward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

  • 02

    Oct

  • 22

    Oct

FINL

Finish Line

$9.22

-0.21 (-2.23%)

09:10
09/22/17
09/22
09:10
09/22/17
09:10
Hot Stocks
Breaking Hot Stocks news story on Finish Line »

Finish Line still sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

DKS

Dick's Sporting

$26.23

-0.31 (-1.17%)

09:05
09/22/17
09/22
09:05
09/22/17
09:05
Hot Stocks
Dick's Sporting to open four new stores in three states in September »

DICK'S Sporting Good…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KTCC

Key Tronic

$6.84

-0.023 (-0.34%)

, CETX

Cemtrex

$3.21

-0.09 (-2.73%)

09:04
09/22/17
09/22
09:04
09/22/17
09:04
Hot Stocks
Bharat Parikh & Associates responds to Key Tronic's allegations »

Bharat Parikh &…

KTCC

Key Tronic

$6.84

-0.023 (-0.34%)

CETX

Cemtrex

$3.21

-0.09 (-2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.